IP Library Granted Patent US 8,481,700
Granted Patent B2
US 8,481,700 · App. 12/678,702 · Granted Jul 9, 2013

Detection of mage-A expression

View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 8,481,700
App. No.
12/678,702
Granted
Jul 9, 2013
Kind
B2
Abstract

An oligonucleotide, primer or probe comprises the nucleotide sequences of any of SEQ ID NO. 5, 6, 7, 2, 3, 4, 8, 9, 11, 12, 13, 14, 15, 16, 17, 18, 19 or 25. The oligonucleotides are useful for the detection of the methylation status of a gene, in particular the MAGE-A3 gene. The oligonucleotides are useful in primer pairs, kits and methods for determining the methylation status of the MAGE-A3 gene and for diagnosing cancer, directing therapy and selecting subjects for treatment. The primer or probe can comprise a loop or hairpin structure and can be used in real-time methylation specific PCR.

Claims (10)

1. A primer pair comprising oligonucleotides or primers consisting of the nucleotide sequence of SEQ ID NO. 6 and 7.

2. A kit for detecting the methylation status of the MAGE-A3 gene comprising the primer pair of claim 1 .

3. A method of detecting unmethylated Mage-A3 gene in a DNA-containing sample, comprising:

(a) contacting and treating the DNA-containing sample with a reagent which selectively modifies unmethylated cytosine residues in the DNA to produce detectable modified residues but which does not modify methylated cytosine residues

(b) amplifying at least a portion of the unmethylated gene of interest using the primer pair of claim 1 .

4. A primer pair comprising oligonucleotides or primers consisting of the nucleotide sequence of SEQ ID NO 2 and 3.

5. A kit for detecting the methylation status of the MAGE-A3 gene comprising the primer pair of claim 4 .

6. A method of detecting umethylated Mage-A3 gene in a DNA-containing sample, comprising:

(a) contacting and treating the DNA-containing sample with a reagent which selectively modifies unmethylated cytosine residues in the DNA to produce detectable modified residues but which does not modify methylated cytosine residues

(b) amplifying at least a portion of the unmethylated gene of interest using the primer pair of claim 4 .

Assignments (5)
NUNC PRO TUNC ASSIGNMENT Recorded Aug 17, 2011
From: VLASSENBROECK, ILSE; BIERAU, KATJA
To: MDXHEALTH SA; GLAXOSMITHKLINE BIOLOGICALS SA
Reel/Frame 026764/0596 →
CORRECTIVE ASSIGNMENT TO CORRECT THE NAME OF THE ASSIGNEE FROM MDXHEALTH TO MDXHEALTH SA PREVIOUSLY RECORDED ON REEL 025584 FRAME 0523. ASSIGNOR(S) HEREBY CONFIRMS THE CORRECT NAME OF THE ASSIGNEE IS MDXHEALTH SA. Recorded Feb 9, 2011
From: MDXHEALTH
To: MDXHEALTH SA
Reel/Frame 025775/0291 →
CHANGE OF NAME Recorded Jan 5, 2011
From: ONCOMETHYLOME SCIENCES
To: MDXHEALTH
Reel/Frame 025584/0523 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Jun 15, 2010
From: VLASSENBROECK, ILSE; BIERAU, KATJA
To: ONCOMETHYLOME SCIENCES SA
Reel/Frame 024538/0788 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Jun 15, 2010
From: ONCOMETHYLOME SCIENCES SA
To: ONCOMETHYLOME SCIENCES SA; GLAXOSMITHKLINE BIOLOGICALS SA
Reel/Frame 024538/0923 →